Onyx Pharma to delay Carfilzomib NDA filing
FDA has requested additional CMC information related to commercial-scale manufacturing of Carfilzomib. Onyx had previously anticipated filing an NDA by the end of 2010 for accelerated approval of

FDA has requested additional CMC information related to commercial-scale manufacturing of Carfilzomib. Onyx had previously anticipated filing an NDA by the end of 2010 for accelerated approval of

In the Phase I trial the female and male subjects were randomly assigned to one of the four groups receiving ascending antigen dose with or without adjuvant which

The new agreements include Hospira’s general infusion medication management technologies, such as the Plum A+ with Hospira MedNet safety software, a scaleable infusion pump system, the Symbiq infusion

ProVation MD replaces dictation and transcription and allows physicians to document procedures at the point of care, streamlines the coding and billing process and enhances compliance by producing

In his role Lubert will be responsible for the technical management of Ricerca’s biotherapeutics assay group and scientific leadership in biotherapeutic development programs. Moreover, his team will assist

The strengths of Losartan Potassium tablets USP approved by FDA are 25mg, 50mg and 100mg while that of Losartan Potassium and Hydrochlorothiazide tablets are 50mg/12.5mg and 100mg/25mg. Roxane

Cambia, a new water-soluble, buffered diclofenac potassium powder, is a prescription non-steroidal anti-inflammatory drug (NSAID) available for the acute treatment of migraine. The companies claimed that Cambia which

Nuevolution said that the DKK24m ($4.48m) project is supported by the Danish High Technology Fund. The collaboration is expected to leverage Nuevolution’s Chemetics technology to screen hundreds of

Specifically, the USPTO has issued claims in three patents covering LNP formulations and lipid components used in Tekmira’s LNP formulations. This includes two issued patents covering the cationic

Turnbull has played different roles in her career including chairman of the New South Wales Government’s Ministerial Advisory Committee on Biotechnology (2001-2), a director of the Sydney Cancer